Earnings Preview: TransMedics Gr
Portfolio Pulse from Benzinga Insights
TransMedics Gr (NASDAQ:TMDX) is scheduled to release its quarterly earnings report on February 26, 2024, with an expected EPS of $-0.03. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historically, TransMedics has had a mixed performance in beating EPS estimates, with significant share price movements following the earnings announcements. The stock has seen a 9.52% increase over the last 52 weeks, trading at $84.81 as of February 22.
February 23, 2024 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
TransMedics Gr is expected to report an EPS of $-0.03 for the upcoming quarter. Historical data shows significant stock price movements post-earnings announcements. The stock has appreciated 9.52% over the last year.
Given TransMedics's history of significant stock price movements following earnings reports and the positive trend over the last year, there's a high likelihood of a positive short-term impact if the company beats the EPS estimate and provides favorable guidance.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100